Rhythm Pharmaceuticals, Inc. (RYTM): Depreciation & Amortization
$500.0K
Year ended 2025-12-31
-17.7%
3-year compound annual growth
-6.2%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $500.0K | -28.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $700.0K | -22.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $900.0K | +0.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $896.0K | +9.8% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $816.0K | +18.3% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $690.0K | -17.3% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $834.0K | +88.7% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $442.0K | +98.2% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $223.0K | +54.9% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $144.0K | n/a | 2019-03-08, From 2016-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $500.0K | -28.6% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.77M | -12.1% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $27.71M | -9.9% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $633.0K | -20.4% |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | $2.70M | +13.1% |
| Liquidia Corp (LQDA) | 2025-12-31 | $1.53M | -30.5% |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $10.94M | -5.1% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $2.31M | -7.1% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $559.0K | -7.8% |
Compare RYTM, LFVN, CYRX, PHAT side by side · Screen every company in Pharmaceutical Preparations ↗